Rosen Firm Ends Bid To Lead NY Pharma Stock-Drop Class
The Rosen Law Firm has agreed to withdraw its application to steer a potential New York stock-drop class accusing an Israeli drug company of securities fraud after the defense said its...To view the full article, register now.
Already a subscriber? Click here to view full article